Wilbanks Smith & Thomas Asset Management »

Vertex Pharmaceuticals Incorporated shares owned by Wilbanks Smith & Thomas Asset Management

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Wilbanks Smith & Thomas Asset Management from 13F filings

Historical chart of Wilbanks Smith & Thomas Asset Management investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Wilbanks Smith & Thomas Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Wilbanks Smith & Thomas Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 2.9k 406.89
2023-09-30 $1.0M 2.9k 347.74
2023-06-30 $1.0M 2.9k 351.91
2023-03-31 $931k 3.0k 315.07
2022-12-31 $855k 3.0k 288.78
2022-09-30 $858k 3.0k 289.57
2022-06-30 $839k 3.0k 281.92
2022-03-31 $795k 3.0k 269.22
2021-12-31 $635k 2.9k 219.50
2021-09-30 $528k 2.9k 181.32
2021-06-30 $591k 2.9k 201.71
2021-03-31 $658k 3.1k 214.75
2020-12-31 $753k 3.2k 236.42
2020-09-30 $862k 3.2k 272.10
2020-06-30 $920k 3.2k 290.40
2020-03-31 $728k 3.1k 238.06
2019-12-31 $626k 2.9k 218.80
2019-09-30 $485k 2.9k 169.52
2019-06-30 $525k 2.9k 183.50
2019-03-31 $526k 2.9k 183.85
2018-12-31 $474k 2.9k 165.68
2018-09-30 $551k 2.9k 192.59
2018-06-30 $486k 2.9k 169.87
2018-03-31 $459k 2.8k 163.06
2017-12-31 $422k 2.8k 149.91
2017-09-30 $522k 3.4k 152.05
2017-06-30 $363k 2.8k 128.95
2017-03-31 $308k 2.8k 109.41
2016-12-31 $207k 2.8k 73.53
2016-09-30 $245k 2.8k 87.03
2016-06-30 $246k 2.9k 86.16
2016-03-31 $227k 2.9k 79.51
2015-12-31 $359k 2.9k 125.74
2015-09-30 $297k 2.9k 104.03
2015-06-30 $353k 2.9k 123.64
2015-03-31 $340k 2.9k 118.10
2014-12-31 $337k 2.8k 118.83
2014-09-30 $316k 2.8k 112.26
2014-06-30 $267k 2.8k 94.85
2013-12-31 $209k 2.8k 74.25
2013-09-30 $216k 2.8k 75.98
2013-06-30 $229k 2.9k 80.01

More positions owned by Wilbanks Smith & Thomas Asset Management

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Norfolk Southern (NSC)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Index Fds Small Cp Etf (VB)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Microsoft Corporation (MSFT)
Ishares Tr Rus Mid Cap Etf (IWR)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)

View all positions for Wilbanks Smith & Thomas Asset Management

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
Alliancebernstein
T. Rowe Price Associates
Jpmorgan Chase & Co
Wellington Management Company
Jennison Associates
Massachusetts Financial Services
Norges Bank Investment Management
Amundi
Bank of America Corporation
Ubs Global Asset Management Americas
ClearBridge Advisors
Legal & General Group
Henderson Group
Bank of New York Mellon

View all funds holding Vertex Pharmaceuticals Incorporated